Literature DB >> 9041055

Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women.

L McClure1, T R Eccleshall, C Gross, M L Villa, N Lin, V Ramaswamy, L Kohlmeier, J L Kelsey, R Marcus, D Feldman.   

Abstract

Common polymorphisms in the vitamin D receptor (VDR) gene have been shown to correlate with bone mineral density (BMD). However, attempts to replicate the original findings in other populations have yielded variable results. These disparities may reflect ethnic or environmental differences in the expression of the VDR effect upon BMD. We examined a relatively ethnically homogeneous group of 103 healthy postmenopausal Caucasian women of Mexican descent living in Northern California. We determined the VDR genotype and measured the BMD at the lumbar spine and femoral neck by dual-energy X-ray absorptiometry, as well as several biochemical indices of mineral metabolism. The prevalence of the BB genotype, associated in previous studies with the lowest BMD, was 8% and highly linked to the tt genotype. Absolute and age-adjusted BMD at both hip and spine showed a trend toward lower BMD in the BB, AA, and tt genotypes, but this trend did not achieve statistical significance. There were no consistent intergroup differences in change in BMD over 2 years of follow-up, nor in mean serum concentrations of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, osteocalcin, or total urinary pyridinolines. Intact parathyroid hormone concentrations were significantly higher in subjects with the AA genotype, with a trend toward higher values in those with the BB and tt genotypes as well. Our data suggest that there may be a decrease in BMD associated with the B, A, and t alleles, but the intergroup difference in BMD is 0.2-0.5 standard deviations (SD) at the lumbar spine and 0.3 SD at the femoral neck, decreases that are smaller than previously reported. Given the relatively low prevalence of the BB/tt genotype in Mexican-American Caucasians, a larger sample would be required to detect a significant association between VDR alleles and differences in BMD of the magnitude suggested by our data. We conclude that a genotype effect of this magnitude, if present, would be clinically relevant, but the impact on BMD is too small to detect with statistical significance in a study of this size.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041055     DOI: 10.1359/jbmr.1997.12.2.234

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  4 in total

1.  Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.

Authors:  Dana E Rollison; Ashley L Cole; Ko-Hui Tung; Martha L Slattery; Kathy B Baumgartner; Tim Byers; Roger K Wolff; Anna R Giuliano
Journal:  Breast Cancer Res Treat       Date:  2011-12-01       Impact factor: 4.872

2.  Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis.

Authors:  Péter Rass; Angéla Pákozdi; Péter Lakatos; Erika Zilahi; Sándor Sipka; Gyula Szegedi; Zoltán Szekanecz
Journal:  Rheumatol Int       Date:  2006-01-31       Impact factor: 2.631

3.  Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor.

Authors:  M H A Malik; F Jury; A Bayat; W E R Ollier; P R Kay
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

4.  The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians.

Authors:  K C Chiu; L M Chuang; C Yoon
Journal:  BMC Med Genet       Date:  2001-02-15       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.